Regulation of tumorigenesis in oral epithelial cells by defined reprogramming factors Oct4 and Sox2

Cai,Jinghua; He,Baoxia; Li,Xinming; Sun,Minglei; Lam,Alfred  King-Yin; Qiao,Bin; Qiu,Weiliu

doi:10.3892/or.2016.4851

Regulation of tumorigenesis in oral epithelial cells by defined reprogramming factors Oct4 and Sox2

Authors:
- Jinghua Cai
- Baoxia He
- Xinming Li
- Minglei Sun
- Alfred King-Yin Lam
- Bin Qiao
- Weiliu Qiu
View Affiliations

Affiliations: Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China, Department of Pharmacy, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou, Henan 450003, P.R. China
Published online on: June 3, 2016 https://doi.org/10.3892/or.2016.4851
Pages: 651-658
Copyright: © Cai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oct4 and Sox2 are pluripotent stem cell factors but the interplay between them in tumorigenesis is unclear. The aim of the present study was to investigate the roles of Oct4 and Sox2 in the reprogramming of oral cancer stem cells. One or both Oct4 and Sox2 were overexpressed in immortalized oral epithelial (hTERT+-OME) cells by lentivirus transduction. In addition, Oct4 and Sox2 proteins in two oral squamous cell carcinoma cell (OSCC) lines (Cal27 and primary cultured OSCC from a T2N2M0 patient) were individually or combinedly knocked down by shRNA. The results showed that the doubly transduced (Oct4+Sox2+) cells could trigger neoplasms in immunodeficient mice after lentivirus transduction, but single transduced (Oct4+ or Sox2+) cells had no tumor formation ability. The knockdown Sox2low and knockdown Oct4lowSox2low cells resulted in decreased tumor size in the immunodeficient mice but the single knockdown Oct4low cancer cells acquired more aggressive xenografts. Our findings suggest that Oct4+Sox2+ cells may be reprogrammed cancer stem cells inducing oral carcinogenesis.

View Figures

View References

1	González-Moles MA, Scully C, Ruiz-Ávila I and Plaza-Campillo JJ: The cancer stem cell hypothesis applied to oral carcinoma. Oral Oncol. 49:738–746. 2013. View Article : Google Scholar : PubMed/NCBI
2	Takahashi K and Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
3	Mattout A, Biran A and Meshorer E: Global epigenetic changes during somatic cell reprogramming to iPS cells. J Mol Cell Biol. 3:341–350. 2011. View Article : Google Scholar : PubMed/NCBI
4	Ohnishi K, Semi K, Yamamoto T, Shimizu M, Tanaka A, Mitsunaga K, Okita K, Osafune K, Arioka Y, Maeda T, et al: Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell. 156:663–677. 2014. View Article : Google Scholar : PubMed/NCBI
5	Yan X, Qin H, Qu C, Tuan RS, Shi S and Huang GT: iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev. 19:469–480. 2010. View Article : Google Scholar :
6	Hobbs RM and Polo JM: Reprogramming can be a transforming experience. Cell Stem Cell. 14:269–271. 2014. View Article : Google Scholar : PubMed/NCBI
7	Adhikary S and Eilers M: Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol. 6:635–645. 2005. View Article : Google Scholar : PubMed/NCBI
8	El-Karim EA, Hagos EG, Ghaleb AM, Yu B and Yang VW: Krüppel-like factor 4 regulates genetic stability in mouse embryonic fibroblasts. Mol Cancer. 12:892013. View Article : Google Scholar
9	Yamanaka S: Pluripotency and nuclear reprogramming. Philos Trans R Soc Lond B Biol Sci. 363:2079–2087. 2008. View Article : Google Scholar : PubMed/NCBI
10	Lin SL: Concise review: Deciphering the mechanism behind induced pluripotent stem cell generation. Stem Cells. 29:1645–1649. 2011. View Article : Google Scholar : PubMed/NCBI
11	Kim JB, Sebastiano V, Wu G, Araúzo-Bravo MJ, Sasse P, Gentile L, Ko K, Ruau D, Ehrich M, van den Boom D, et al: Oct4-induced pluripotency in adult neural stem cells. Cell. 136:411–419. 2009. View Article : Google Scholar : PubMed/NCBI
12	Islam F, Qiao B, Smith RA, Gopalan V and Lam AK: Cancer stem cell: Fundamental experimental pathological concepts and updates. Exp Mol Pathol. 98:184–191. 2015. View Article : Google Scholar : PubMed/NCBI
13	Qiao B, Gopalan V, Chen Z, Smith RA, Tao Q and Lam AK: Epithelial-mesenchymal transition and mesenchymal-epithelial transition are essential for the acquisition of stem cell properties in hTERT-immortalised oral epithelial cells. Biol Cell. 104:476–489. 2012. View Article : Google Scholar : PubMed/NCBI
14	Smalley M and Ashworth A: Stem cells and breast cancer: A field in transit. Nat Rev Cancer. 3:832–844. 2003. View Article : Google Scholar : PubMed/NCBI
15	Sugii S, Kida Y, Berggren WT and Evans RM: Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells. Nat Protoc. 6:346–358. 2011. View Article : Google Scholar : PubMed/NCBI
16	Ellis P, Fagan BM, Magness ST, Hutton S, Taranova O, Hayashi S, McMahon A, Rao M and Pevny L: SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev Neurosci. 26:148–165. 2004. View Article : Google Scholar
17	Nishi M, Sakai Y, Akutsu H, Nagashima Y, Quinn G, Masui S, Kimura H, Perrem K, Umezawa A, Yamamoto N, et al: Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors. Oncogene. 33:643–652. 2014. View Article : Google Scholar
18	Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF and Brooks SC: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50:6075–6086. 1990.PubMed/NCBI
19	Hochedlinger K, Yamada Y, Beard C and Jaenisch R: Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell. 121:465–477. 2005. View Article : Google Scholar : PubMed/NCBI
20	Guo CL, Liu L, Jia YD, Zhao XY, Zhou Q and Wang L: A novel variant of Oct3/4 gene in mouse embryonic stem cells. Stem Cell Res. 9:69–76. 2012. View Article : Google Scholar : PubMed/NCBI
21	Liu L, Wei X, Ling J, Wu L and Xiao Y: Expression pattern of Oct-4, Sox2, and c-Myc in the primary culture of human dental pulp derived cells. J Endod. 37:466–472. 2011. View Article : Google Scholar : PubMed/NCBI
22	Qiao B, He B, Cai J and Yang W: The expression profile of Oct4 and Sox2 in the carcinogenesis of oral mucosa. Int J Clin Exp Pathol. 7:28–37. 2013.
23	Arnold K, Sarkar A, Yram MA, Polo JM, Bronson R, Sengupta S, Seandel M, Geijsen N and Hochedlinger K: Sox2⁺ adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell. 9:317–329. 2011. View Article : Google Scholar : PubMed/NCBI
24	Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, Takahashi K, Okochi H, Okuda A, Matoba R, Sharov AA, et al: Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol. 9:625–635. 2007. View Article : Google Scholar : PubMed/NCBI
25	Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, Gimotty PA, Guerra M, Guo W and Xu X: Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene. 31:4898–4911. 2012. View Article : Google Scholar : PubMed/NCBI
26	Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, Elorriaga K, Pandiella A, Rezola R and Martin AG: Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene. 31:1354–1365. 2012. View Article : Google Scholar
27	Kopp JL, Ormsbee BD, Desler M and Rizzino A: Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells. 26:903–911. 2008. View Article : Google Scholar : PubMed/NCBI
28	Niwa H, Miyazaki J and Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 24:372–376. 2000. View Article : Google Scholar : PubMed/NCBI